Previous Article | Next Article 
Journal of Virology, October 2001, p. 9596-9600, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9596-9600.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Interleukin-12- and Gamma Interferon-Dependent Innate
Immunity Are Essential and Sufficient for Long-Term Survival of
Passively Immunized Mice Infected with Herpes Simplex Virus Type
1
Sabine
Vollstedt,1
Marco
Franchini,1
Gottfried
Alber,2
Mathias
Ackermann,1 and
Mark
Suter1,*
Institute of Virology, University of Zurich,
Zurich, Switzerland,1 and Institute of
Immunology, Faculty of Veterinary Medicine, University of Leipzig,
Leipzig, Germany2
Received 16 April 2001/Accepted 12 July 2001
Interferon (IFN) type I (alpha/beta IFN [IFN-
/
]) is very
important in directly controlling herpes simplex virus type I (HSV-1) replication as well as in guiding and upregulating specific immunity against this virus. By contrast, the roles of IFN type II (IFN-
) and
antibodies in the defense against HSV-1 are not clear. Mice without a
functional IFN system and no mature B and T cells (AGR mice) did not
survive HSV-1 infection in the presence or absence of neutralizing
antibodies to the virus. Mice without a functional IFN type I system
and with no mature B and T cells (AR129 mice) were unable to control
infection with as little as 10 PFU of HSV-1 strain F. By contrast, in
the presence of passively administered neutralizing murine antibodies
to HSV-1, some AR129 mice survived infection with up to104
PFU of HSV-1. This acute immune response was dependent on the presence
of interleukin-12 (IL-12) p75. Interestingly, some virus-infected mice
stayed healthy for several months, at which time antibody to HSV-1 was
no longer detectable. Treatment of these virus-exposed mice with
dexamethasone led to death in approximately 40% of the mice. HSV-1 was
found in brains of mice that did not survive dexamethasone treatment,
whereas HSV-1 was absent in those that survived the treatment. We
conclude that in the presence of passively administered HSV-1-specific
antibodies, the IL-12-induced IFN-
-dependent innate immune response
is able to control low doses of virus infection. Surprisingly, in a
significant proportion of these mice, HSV-1 appears to persist in the
absence of antibodies and specific immunity.
*
Corresponding author. Mailing address: Institute of
Virology, University of Zurich, Winterthurerstr. 266a, CH-8057 Zurich, Switzerland. Phone: 41 1 635 87 17. Fax: 41 1 635 89 11. E-mail: msuter{at}vetvir.unizh.ch.
Journal of Virology, October 2001, p. 9596-9600, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9596-9600.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liu, Y., Haas, D. L., Poore, S., Isakovic, S., Gahan, M., Mahalingam, S., Fu, Z. F., Tripp, R. A.
(2009). Human Metapneumovirus Establishes Persistent Infection in the Lungs of Mice and Is Reactivated by Glucocorticoid Treatment. J. Virol.
83: 6837-6848
[Abstract]
[Full Text]
-
Sorensen, L. N., Reinert, L. S., Malmgaard, L., Bartholdy, C., Thomsen, A. R., Paludan, S. R.
(2008). TLR2 and TLR9 Synergistically Control Herpes Simplex Virus Infection in the Brain. J. Immunol.
181: 8604-8612
[Abstract]
[Full Text]
-
Banerjee, K., Biswas, P. S., Rouse, B. T.
(2005). Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J. Leukoc. Biol.
77: 24-32
[Abstract]
[Full Text]
-
Banerjee, K., Biswas, P. S., Kumaraguru, U., Schoenberger, S. P., Rouse, B. T.
(2004). Protective and Pathological Roles of Virus-Specific and Bystander CD8+ T Cells in Herpetic Stromal Keratitis. J. Immunol.
173: 7575-7583
[Abstract]
[Full Text]
-
Pollara, G., Jones, M., Handley, M. E., Rajpopat, M., Kwan, A., Coffin, R. S., Foster, G., Chain, B., Katz, D. R.
(2004). Herpes Simplex Virus Type-1-Induced Activation of Myeloid Dendritic Cells: The Roles of Virus Cell Interaction and Paracrine Type I IFN Secretion. J. Immunol.
173: 4108-4119
[Abstract]
[Full Text]
-
Vollstedt, S., Arnold, S., Schwerdel, C., Franchini, M., Alber, G., Di Santo, J. P., Ackermann, M., Suter, M.
(2004). Interplay between Alpha/Beta and Gamma Interferons with B, T, and Natural Killer Cells in the Defense against Herpes Simplex Virus Type 1. J. Virol.
78: 3846-3850
[Abstract]
[Full Text]
-
Friedl, G., Hofer, M., Auber, B., Sauder, C., Hausmann, J., Staeheli, P., Pagenstecher, A.
(2004). Borna Disease Virus Multiplication in Mouse Organotypic Slice Cultures Is Site-Specifically Inhibited by Gamma Interferon but Not by Interleukin-12. J. Virol.
78: 1212-1218
[Abstract]
[Full Text]
-
Hooks, J. J., Wang, Y., Detrick, B.
(2003). The Critical Role of IFN-{gamma} in Experimental Coronavirus Retinopathy. IOVS
44: 3402-3408
[Abstract]
[Full Text]
-
Glass, W. G., Lane, T. E.
(2002). Functional Expression of Chemokine Receptor CCR5 on CD4+ T Cells during Virus-Induced Central Nervous System Disease. J. Virol.
77: 191-198
[Abstract]
[Full Text]
-
Freude, S., Hausmann, J., Hofer, M., Pham-Mitchell, N., Campbell, I. L., Staeheli, P., Pagenstecher, A.
(2002). Borna Disease Virus Accelerates Inflammation and Disease Associated with Transgenic Expression of Interleukin-12 in the Central Nervous System. J. Virol.
76: 12223-12232
[Abstract]
[Full Text]
-
Pyles, R. B., Higgins, D., Chalk, C., Zalar, A., Eiden, J., Brown, C., Van Nest, G., Stanberry, L. R.
(2002). Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection. J. Virol.
76: 11387-11396
[Abstract]
[Full Text]
-
Carr, D. J. J., Noisakran, S.
(2002). The Antiviral Efficacy of the Murine Alpha-1 Interferon Transgene against Ocular Herpes Simplex Virus Type 1 Requires the Presence of CD4+, {alpha}/{beta} T-Cell Receptor-Positive T Lymphocytes with the Capacity To Produce Gamma Interferon. J. Virol.
76: 9398-9406
[Abstract]
[Full Text]
-
Brockman, M. A., Knipe, D. M.
(2002). Herpes Simplex Virus Vectors Elicit Durable Immune Responses in the Presence of Preexisting Host Immunity. J. Virol.
76: 3678-3687
[Abstract]
[Full Text]